<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Strict//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-strict.dtd"><html xml:lang="en" lang="en" xmlns="http://www.w3.org/1999/xhtml"><head><meta http-equiv="Content-Type" content="text/html; charset=utf-8" /><meta name="ROBOTS" content="NOARCHIVE" /><meta name="googlebot" content="nosnippet" /><meta name="Document-Type" content="sub-topic" /><meta name="keywords" content="Tuberculosis: prophylaxis" /><meta name="IX" content="Tuberculosis: prophylaxis" /><title>Prevention of tuberculosis in susceptible close contacts or those who have become tuberculin positive(1): British National Formulary</title><link type="text/css" rel="stylesheet" href="../../theme/theme.css" /><link type="text/css" rel="stylesheet" href="../../theme/print.css" media="print" /><link type="text/css" rel="stylesheet" href="59/style.css" /><link type="image/x-icon" rel="shortcut icon" href="favicon.ico" /><link rel="stylesheet" type="text/css" href="style/screen.css" media="screen" /><link rel="stylesheet" type="text/css" href="style/print.css" media="print" /><link rel="contents" type="text/html" href="index.htm" /><link rel="help" type="text/html" href="http://www.medicinescomplete.com/mc/help_page.htm" /><link rel="start" type="text/html" href="index.htm" title="British National Formulary" /><link rel="copyright" type="text/html" href="PHP0-publication-information.htm" title="Copyright information" /><link rel="bookmark" title="Skip Navigation" href="PHP3285-prevention-of-tuberculosis-in-susceptible-close-contacts-or-those-who-have-become-tuberculin-positive.htm#pB" /><script type="text/javascript" src="https://ajax.googleapis.com/ajax/libs/jquery/1.7.0/jquery.min.js"></script><script type="text/javascript" src="../../scripts/jquery/jquery.tooltip.min.js"></script><script type="text/javascript" src="../../scripts/jquery/jquery.cookie.js"></script><script type="text/javascript" src="../../scripts/jquery/jquery.autosuggest.js"></script><script type="text/javascript" src="../../scripts/scripts.js"></script><style type="text/css">
  .contentsbox { position: fixed; z-index:1001;}
  .contentsbox_wrap {overflow:hidden;width:20px;height:130px; position:absolute;left:0;top:0;}
</style><!--[if lte IE 7]>
          <style type="text/css">
          .contentsbox {
          position: absolute;
          left: expression( ( 15 + ( ignoreMe2 = document.documentElement.scrollLeft ? document.documentElement.scrollLeft : document.body.scrollLeft ) ) + 'px' );
          top: expression( ( 250 + ( ignoreMe = document.documentElement.scrollTop ? document.documentElement.scrollTop : document.body.scrollTop) ) + 'px' );
          }
          .threecol_col3 {
          font-family: arial
          }
          .threecol_col3 a {
          font-family: verdana,helvetica,sans-serif
          }
          .threecol_col1 {
          font-family: arial
          }
          .threecol_col1 a {
          font-family: verdana,helvetica,sans-serif
          }
          div#pE {
          font-family: arial
          }
          div#pE a {
          font-family: verdana,helvetica,sans-serif
          }
          div#pK {
          font-family: arial
          }
          div#pK a {
          font-family: verdana,helvetica,sans-serif
          }
          </style>
          <![endif]--></head><body><?highlighter off?><div id="pU"><a id="pD" accesskey="s" rel="bookmark" href="PHP3285-prevention-of-tuberculosis-in-susceptible-close-contacts-or-those-who-have-become-tuberculin-positive.htm#pB" title="Skip Navigation">Skip Navigation</a><img src="../../images/mylogo.png" alt="BNF.org Free Access" id="pI" /><ul id="pZ"><li><a href="http://www.medicinescomplete.com/mc/account.htm">You are signed in as a member of <b>BNF.org Free Access</b></a></li><li> | <a href="http://www.medicinescomplete.com/mc/login.htm">Sign in different user</a></li><li> | <a href="http://www.medicinescomplete.com/mc/logout.htm">Sign out</a></li></ul><a href="http://www.medicinescomplete.com/mc/" title="Go to the MedicinesComplete home page"><img src="../../images/mc.png" alt="MedicinesComplete" /></a><ul id="pM"><li><a href="http://www.medicinescomplete.com/mc/" class="selected" accesskey="1" title="Home: access key 1"><strong><span>Home</span></strong></a></li><li><a href="http://www.medicinescomplete.com/mc/marketing/current/"><strong><span>Welcome</span></strong></a></li><li><a href="http://www.medicinescomplete.com/mc/feedback.htm?pub=bnf&amp;uri=PHP3285-prevention-of-tuberculosis-in-susceptible-close-contacts-or-those-who-have-become-tuberculin-positive.htm" accesskey="9" title="Feedback: access key 9"><strong><span>Feedback</span></strong></a></li><li><a href="http://www.medicinescomplete.com/mc/help.htm" accesskey="6" title="Help button: access key 6"><strong><span>Help</span></strong></a></li></ul></div><div id="pA"><div id="pY">British National Formulary</div><div id="pG">Printed from: Joint Formulary Committee.  <i>British National Formulary</i>. [online] London: BMJ Group and Pharmaceutical Press.. &lt; http://www.medicinescomplete.com/ &gt; [Accessed on 06 Oct 2012 (GMT)].</div><div id="pQ"><form id="searchForm" method="get" action="http://www.medicinescomplete.com/mc/bnf/current/search.htm"><fieldset><legend>Details</legend><label for="q">Search for</label><div id="qd"><div><input accesskey="4" type="text" id="q" name="q" /><input class="button" id="searchButton" type="submit" value="Search" name="searchButton" title="Search full text" /></div></div></fieldset></form><script type="text/javascript">$(document).ready(function(){$("#q").autoSuggest('http://www.medicinescomplete.com/mc/bnf/current/search/suggest.xml', {control: "#searchButton"});});</script></div></div><div id="pH"><div id="pN"><div id="pT"><span class="cA"><a href="http://www.medicinescomplete.com/mc/">Home</a></span> &gt; <a href="index.htm">BNF September 2012</a> &gt; <a href="PHP3253-infections.htm">5 Infections</a> &gt; <a href="PHP3256-antibacterial-drugs.htm">5.1 Antibacterial drugs</a> &gt; <a href="PHP3277-table-2-summary-of-antibacterial-prophylaxis.htm">Table 2. Summary of antibacterial prophylaxis</a></div><div id="pP"><div class="threecol_col1">◄ <a accesskey="[" href="PHP3284-prevention-of-pneumococcal-infection-in-asplenia-or-in-patients-with-sickle-cell-disease.htm" title="Previous: Prevention of pneumococcal infection in asplenia or in patients with sickle-cell disease">Previous page</a></div><div class="threecol_col2"> </div><div class="threecol_col3"><a accesskey="]" href="PHP3286-prevention-of-infection-from-animal-and-human-bites.htm" title="Next: Prevention of infection from animal and human bites">Next page</a> ►</div></div></div></div><div id="p1"><div id="sideBar"><h2>See Also</h2><ul><li><h3>British National Formulary (4)</h3></li><li><a href="PHP3588-antituberculosis-drugs.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">5.1.9 Antituberculosis drugs</a><div class="breadcrumb"><p><strong>British National Formulary</strong> &gt; 5 Infections &gt; 5.1 Antibacterial drugs</p></div></li><li><a href="PHP8247-bcg-vaccines.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">BCG vaccines</a><div class="breadcrumb"><p><strong>British National Formulary</strong> &gt; 14 Immunological products and vaccines &gt; 14.4 Vaccines and antisera</p></div></li><li><a href="PHP8252-diagnostic-agents.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Diagnostic agents</a><div class="breadcrumb"><p><strong>British National Formulary</strong> &gt; 14 Immunological products and vaccines &gt; 14.4 Vaccines and antisera &gt; BCG vaccines</p></div></li><li><a class="seeAll" href="http://www.medicinescomplete.com/mc/related.htm?q=%22tuberculosis%22" onclick="pageTracker._trackEvent('Related-Topic','Related-See-All');">see all (4)</a></li></ul><ul><li><h3>BNF for Children (7)</h3></li><li><a href="http://www.medicinescomplete.com/mc/bnfc/2011/PHP12639-prevention-of-tuberculosis-in-susceptible-close-contacts-or-those-who-have-become-tuberculin-positive.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Prevention of tuberculosis in susceptible close contacts or those who have become tuberculin positive</a><div class="breadcrumb"><p><strong>BNF for Children</strong> &gt; 5 Infections &gt; 5.1 Antibacterial drugs &gt; Table 2. Summary of antibacterial prophylaxis</p></div></li><li><a href="http://www.medicinescomplete.com/mc/bnfc/2011/PHP12840-antituberculosis-drugs.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">5.1.9 Antituberculosis drugs</a><div class="breadcrumb"><p><strong>BNF for Children</strong> &gt; 5 Infections &gt; 5.1 Antibacterial drugs</p></div></li><li><a href="http://www.medicinescomplete.com/mc/bnfc/2011/PHP12875-streptomycin.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">STREPTOMYCIN</a><div class="breadcrumb"><p><strong>BNF for Children</strong> &gt; 5 Infections &gt; 5.1 Antibacterial drugs &gt; 5.1.9 Antituberculosis drugs</p></div></li><li><a class="seeAll" href="http://www.medicinescomplete.com/mc/related.htm?q=%22tuberculosis%22" onclick="pageTracker._trackEvent('Related-Topic','Related-See-All');">see all (7)</a></li></ul><ul><li><h3>Dietary Supplements</h3></li><li><a href="http://www.medicinescomplete.com/mc/diet/2010/c101.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Vitamin E</a><div class="breadcrumb"><p><strong>Dietary Supplements</strong> &gt; Monographs &gt; V</p></div></li></ul><ul><li><h3>Martindale: The Complete Drug Reference (3)</h3></li><li><a href="http://www.medicinescomplete.com/mc/martindale/2009/1-a5-496-l.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Tuberculosis</a><div class="breadcrumb"><p><strong>Martindale: The Complete Drug Reference</strong> &gt; Drugs and Ancillary Substances &gt; By therapeutic use &gt; Antibacterials &gt; Choice of Antibacterial</p></div></li><li><a href="http://www.medicinescomplete.com/mc/martindale/2009/7936-m.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">BCG Vaccines</a><div class="breadcrumb"><p><strong>Martindale: The Complete Drug Reference</strong> &gt; Drugs and Ancillary Substances &gt; By therapeutic use &gt; Vaccines Immunoglobulins and Antisera &gt; Drug Monographs</p></div></li><li><a href="http://www.medicinescomplete.com/mc/martindale/2009/8024-k.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Tuberculins</a><div class="breadcrumb"><p><strong>Martindale: The Complete Drug Reference</strong> &gt; Drugs and Ancillary Substances &gt; By therapeutic use &gt; Miscellaneous Drugs and Other Substances &gt; Drug Monographs</p></div></li></ul><ul><li><h3>Rules &amp; Guidance for Pharmaceutical Manufacturers &amp; Distributors</h3></li><li><a href="http://www.medicinescomplete.com/mc/orange/2009/c05sec1006.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Schedule 3 of the Regulations</a><div class="breadcrumb"><p><strong>Rules &amp; Guidance for Pharmaceutical Manufacturers &amp; Distributors</strong> &gt; III  LEGISLATION ON MANUFACTURE &gt; 5  UK Legislation on Manufacture</p></div></li></ul><ul><li><h3>Remington: The Science and Practice of Pharmacy (5)</h3></li><li><a href="http://www.medicinescomplete.com/mc/rem/2012/c11-sec1-001.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Applications of Radionuclides in Medicine and Pharmacy</a><div class="breadcrumb"><p><strong>Remington: The Science and Practice of Pharmacy</strong> &gt; Part 1: The Science of Pharmacy &gt; Section 2: Pharmaceutical Chemistry &gt; 11 Fundamentals of Medical Radionuclides</p></div></li><li><a href="http://www.medicinescomplete.com/mc/rem/2012/c80-sec1-0010.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Communicable Diseases Control</a><div class="breadcrumb"><p><strong>Remington: The Science and Practice of Pharmacy</strong> &gt; Part 2: The Practice of Pharmacy &gt; Section 8: The Scope of Pharmacy Practice &gt; 80 Pharmacists and Public Health</p></div></li><li><a href="http://www.medicinescomplete.com/mc/rem/2012/c87-sec1-0021.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Pyridoxine (Vitamin B6)</a><div class="breadcrumb"><p><strong>Remington: The Science and Practice of Pharmacy</strong> &gt; Part 2: The Practice of Pharmacy &gt; Section 8: The Scope of Pharmacy Practice &gt; 87 Nutrients and Associated Substances</p></div></li><li><a class="seeAll" href="http://www.medicinescomplete.com/mc/related.htm?q=%22tuberculosis%22" onclick="pageTracker._trackEvent('Related-Topic','Related-See-All');">see all (5)</a></li></ul><script type="text/javascript" src="scripts/sidebar.js"></script></div><div id="pB"><h1>Prevention of tuberculosis in susceptible close contacts or those who have become tuberculin positive<span><cite><a href="PHP3285-prevention-of-tuberculosis-in-susceptible-close-contacts-or-those-who-have-become-tuberculin-positive.htm#ID0EAACA" class="tooltip ID0EAACA">(1)</a></cite></span></h1><?highlighter on?><div id="pC" class="jN"><p>Isoniazid 300 mg daily for 6 months; <span class="cP">child</span> 10 mg/kg daily (max. 300 mg daily)</p><p><em>or</em> isoniazid 300 mg daily + rifampicin 600 mg daily (450 mg if less than 50 kg) for 3 months; <span class="cP">child</span> isoniazid 10 mg/kg daily (max. 300 mg daily) + rifampicin 10 mg/kg daily (max. 450 mg daily if body-weight less than 50 kg; max. 600 mg daily if body-weight over 50 kg)</p><p><em>or</em> (if isoniazid-resistant tuberculosis in patients under 35 years) rifampicin 600 mg daily (450 mg if less than 50 kg) for 6 months; <span class="cP">child</span> 10 mg/kg daily (max. 450 mg daily if body-weight less than 50 kg; max. 600 mg daily if body-weight over 50 kg)</p></div><?highlighter off?><div id="pE">◄ <a accesskey="[" href="PHP3284-prevention-of-pneumococcal-infection-in-asplenia-or-in-patients-with-sickle-cell-disease.htm">Previous: Prevention of pneumococcal infection in asplenia or in patients with sickle-cell disease</a> | <a class="top" href="PHP3285-prevention-of-tuberculosis-in-susceptible-close-contacts-or-those-who-have-become-tuberculin-positive.htm#">Top</a> | <a accesskey="]" href="PHP3286-prevention-of-infection-from-animal-and-human-bites.htm">Next: Prevention of infection from animal and human bites</a> ►</div><ol class="cC"><li class="footnote" id="ID0EAACA"><p>For details of those who should receive chemoprophylaxis contact the lead clinician for local tuberculosis services (or a consultant in communicable disease control). See also <a title=" Antituberculous drugs" href="PHP3588-antituberculosis-drugs.htm">section 5.1.9</a>, for advice on immunocompromised patients and on prevention of tuberculosis</p></li></ol></div></div><div id="pF"><div id="pL"><div id="footer"><div id="footerinner"><ul><li><a accesskey="0" href="accessibility.htm" title="Accessibility information: access key 0">Accessibility</a> | </li><li><a href="http://www.medicinescomplete.com/mc/marketing/current/contact.htm">Contact Us</a> | </li><li><a href="privacy.htm" title="Cookie and Privacy Policy">Cookie and Privacy Policy</a> | </li><li><a accesskey="3" href="http://www.medicinescomplete.com/mc/sitemap.htm" title="Site Map: access key 3">Site Map</a> | </li><li><a accesskey="8" href="terms.htm" title="Terms and Conditions: access key 8">Terms and Conditions</a></li></ul></div></div></div><div id="pX"><p><a href="PHP0-publication-information.htm" rel="copyright">Copyright © BMJ Group and Pharmaceutical Press 2012. All rights reserved. </a></p></div></div><script type="text/javascript">$(document).ready(function(){$.ga('UA-9959526-1');});</script></body></html>